Response by Barreto and Grotta to Letter Regarding Article, “Randomized, Multicenter Trial of ARTSS-2 (Argatroban With Recombinant Tissue Plasminogen Activator for Acute Stroke)” [Letter to the Editor]

Source: Stroke - Category: Neurology Authors: Tags: Anticoagulants, Treatment, Cerebrovascular Disease/Stroke, Thrombosis Letters to the Editor Source Type: research
More News: Stroke | Thrombosis